Advertisement

Clinical application of stress echocardiography for valvular heart disease

  • Kenya KusunoseEmail author
Special Feature: Review Article Echocardiographic management of valvular heart disease

Abstract

Stress echocardiography is widely used to assess several cardiovascular diseases, including ischemic heart disease, valvular heart disease (VHD), heart failure, congenital heart disease, and pulmonary hypertension. In valvular heart disease with asymptomatic severe or symptomatic non-severe status, stress echocardiography plays a central role in the management. As of 2017, the updated American College of Cardiology/American Heart Association and European Society of Cardiology/European Association for Cardio-Thoracic Surgery VHD guidelines recommended stress testing to (1) confirm symptoms and (2) evaluate the hemodynamic response to exercise. In patients with undetermined VHD severity in the presence of low-flow status, it can also be helpful to determine whether the VHD is severe based on flow-dependent changes in response to stress. The clinical indications of stress echocardiography in VHD have expanded with growing evidence for prognosis and being an early marker for interventions. As a result, demand has increased in major cardiology societies for the standardization of stress echocardiography in VHD. Echocardiographic centers should be aware of the clinical potential of stress echocardiography to ensure its optimal application and performance in VHD. This article reviews the clinical application of stress echocardiography, including dobutamine, semisupine bicycle, treadmill, and leg-positive pressure for VHD patient management, and focuses on the current consensus regarding the use of stress echocardiography in VHD. Stress echocardiography is safe and should be encouraged, especially in heart valve clinics, to understand the complex mechanism in asymptomatic patients.

Keywords

Dobutmaine Treadmill Semisupine bicycle Echocardiography Stress echocardiography 

Notes

Acknowledgements

The author thanks Robert Zheng, MD, for revising the manuscript.

Funding

None.

Compliance with ethical standards

Conflict of interest

The author declares that there is no conflict of interest.

Ethical statements

All the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

References

  1. 1.
    Andell P, Li X, Martinsson A, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart. 2017;103:1696–703.CrossRefGoogle Scholar
  2. 2.
    Watanabe N, Nishino S, Shibata Y. Simple and easy quantitation of functional mitral valve area using novel automated flow measurement technique with real-time 3-D color Doppler echocardiography. J Echocardiogr. 2018;16:189–91.CrossRefGoogle Scholar
  3. 3.
    Koto D, Izumo M, Machida T, et al. Geometry of the left ventricular outflow tract assessed by 3D TEE in patients with aortic stenosis: impact of upper septal hypertrophy on measurements of Doppler-derived left ventricular stroke volume. J Echocardiogr. 2018;16:162–72.CrossRefGoogle Scholar
  4. 4.
    Tumenbayar M, Yamaguchi K, Yoshitomi H, et al. Increased apical rotation in patients with severe aortic stenosis assessed by three-dimensional speckle tracking imaging. J Echocardiogr. 2018;16:28–33.CrossRefGoogle Scholar
  5. 5.
    Picano E, Ciampi Q, Citro R, et al. Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease. Cardiovasc Ultrasound. 2017;15:3.CrossRefGoogle Scholar
  6. 6.
    Lancellotti P, Dulgheru R, Go YY, et al. Stress echocardiography in patients with native valvular heart disease. Heart. 2018;104:807–13.CrossRefGoogle Scholar
  7. 7.
    Lancellotti P, Pellikka PA, Budts W, et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2016;17:1191–229.CrossRefGoogle Scholar
  8. 8.
    Li W, West C, McGhie J, et al. Consensus recommendations for echocardiography in adults with congenital heart defects from the International Society of Adult Congenital Heart Disease (ISACHD). Int J Cardiol. 2018;272:77–83.CrossRefGoogle Scholar
  9. 9.
    Kusunose K, Yamada H. Rest and exercise echocardiography for early detection of pulmonary hypertension. J Echocardiogr. 2016;14:2–12.CrossRefGoogle Scholar
  10. 10.
    Suzuki T, Izumo M, Suzuki K, et al. Prognostic value of exercise stress echocardiography in patients with secondary mitral regurgitation: a long-term follow-up study. J Echocardiogr. 2018.  https://doi.org/10.1007/s12574-018-0404-6.Google Scholar
  11. 11.
    Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252–89.CrossRefGoogle Scholar
  12. 12.
    Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.CrossRefGoogle Scholar
  13. 13.
    Magne J, Donal E, Mohty D, et al. Stress echocardiography in aortic valve disease. Advances in treatments for aortic valve and root diseases. Cham: Springer; 2018. p. 83–93.CrossRefGoogle Scholar
  14. 14.
    Kusunose K, Yamada H, Nishio S, et al. Preload stress echocardiography predicts outcomes in patients with preserved ejection fraction and low-gradient aortic stenosis. Circ Cardiovasc Imaging. 2017;10:e006690.CrossRefGoogle Scholar
  15. 15.
    Kusunose K, Agarwal S, Marwick TH, et al. Decision making in asymptomatic aortic regurgitation in the era of guidelines: incremental values of resting and exercise cardiac dysfunction. Circ Cardiovasc Imaging. 2014;7:352–62.CrossRefGoogle Scholar
  16. 16.
    Kusunose K, Popovic ZB, Motoki H, et al. Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging. 2013;6:167–76.CrossRefGoogle Scholar
  17. 17.
    Reis G, Motta MS, Barbosa MM, et al. Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosis. J Am Coll Cardiol. 2004;43:393–401.CrossRefGoogle Scholar
  18. 18.
    Magne J, Lancellotti P, Pierard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation. 2010;122:33–41.CrossRefGoogle Scholar
  19. 19.
    Magne J, Pibarot P, Sengupta PP, et al. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. JACC Cardiovasc Imaging. 2015;8:83–99.CrossRefGoogle Scholar
  20. 20.
    Magne J, Donal E, Mahjoub H, et al. Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation. Heart. 2015;101:391–6.CrossRefGoogle Scholar
  21. 21.
    Pierard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med. 2004;351:1627–34.CrossRefGoogle Scholar
  22. 22.
    Dhoble A, Sarano ME, Kopecky SL, et al. Safety of symptom-limited cardiopulmonary exercise testing in patients with aortic stenosis. Am J Med. 2012;125:704–8.CrossRefGoogle Scholar
  23. 23.
    van Le D, Jensen GV, Carstensen S, et al. Cardiopulmonary exercise testing in patients with asymptomatic or equivocal symptomatic aortic stenosis: feasibility, reproducibility, safety and information obtained on exercise physiology. Cardiology. 2016;133:147–56.CrossRefGoogle Scholar
  24. 24.
    Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108:319–24.CrossRefGoogle Scholar
  25. 25.
    Bhattacharyya S, Khattar R, Chahal N, et al. Dynamic assessment of stenotic valvular heart disease by stress echocardiography. Circ Cardiovasc Imaging. 2013;6:583–9.CrossRefGoogle Scholar
  26. 26.
    Clavel MA, Burwash IG, Mundigler G, et al. Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study. J Am Soc Echocardiogr. 2010;23:380–6.CrossRefGoogle Scholar
  27. 27.
    Dumesnil JG, Pibarot P, Carabello B. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J. 2010;31:281–9.CrossRefGoogle Scholar
  28. 28.
    Saijo Y, Yamada H, Kusunose K, et al. A clinical application of preload stress echocardiography for predicting future hemodynamic worsening in patients with early-stage heart failure. Echocardiography. 2018;35:1587–95.CrossRefGoogle Scholar
  29. 29.
    Matsumoto K, Onishi A, Yamada H, et al. Noninvasive assessment of preload reserve enhances risk stratification of patients with heart failure with reduced ejection fraction. Circ Cardiovasc Imaging. 2018;11:e007160.CrossRefGoogle Scholar
  30. 30.
    Kusunose K, Yamada H, Nishio S, et al. RV myocardial strain during pre-load augmentation is associated with exercise capacity in patients with chronic HF. JACC Cardiovasc Imaging. 2017;10:1240–9.CrossRefGoogle Scholar
  31. 31.
    Yamada H, Kusunose K, Nishio S, et al. Pre-load stress echocardiography for predicting the prognosis in mild heart failure. JACC Cardiovasc Imaging. 2014;7:641–9.CrossRefGoogle Scholar
  32. 32.
    Kusunose K, Yamada H, Nishio S, et al. Interval from the onset of transmitral flow to annular velocity is a marker of LV filling pressure. JACC Cardiovasc Imaging. 2013;6:528–30.CrossRefGoogle Scholar
  33. 33.
    Bonow RO, Lakatos E, Maron BJ, et al. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation. 1991;84:1625–35.CrossRefGoogle Scholar
  34. 34.
    Wahi S, Haluska B, Pasquet A, et al. Exercise echocardiography predicts development of left ventricular dysfunction in medically and surgically treated patients with asymptomatic severe aortic regurgitation. Heart. 2000;84:606–14.CrossRefGoogle Scholar

Copyright information

© The Japan Society of Ultrasonics in Medicine 2019

Authors and Affiliations

  1. 1.Department of Cardiovascular MedicineTokushima University HospitalTokushimaJapan

Personalised recommendations